Document is current
Any future updates will be listed below
-
Authors
Shigeta, Naoko
Murakami, Shuji
Yamamoto, Kouji
Yokose, Tomoyuki
Isaka, Tetsuya
Washimi, Kota
Miyagi, Yohei
Saito, Haruhiro
Ito, Hiroyuki
Saito, Aya
- License Information
-
More Information
Article History
Received: 21 November 2024
Accepted: 31 March 2025
First Online: 14 April 2025
Declarations
:
: Approval of the research protocol by an Institutional Reviewer Board: Ethical approval for this study was obtained from the Kanagawa Cancer Center (No. 2023 − 149). The study was conducted in accordance with the Declaration of Helsinki.
: Informed consent was obtained from all patients.
: N/A.
: N/A.
: Financial interests: Shuji Murakami reports personal fees from Ono Pharmaceutical, Bristol Myers Squibb and MSD. Haruhiro Saito reports grants from Ono Pharmaceutical and personal fees from Ono Pharmaceutical, Bristol Myers Squibb, MSD. Hiroyuki Ito reports personal fees from Chugai Pharmaceutical, Ono Pharmaceutical and Bristol Myers Squibb. The other authors have no relevant financial or non-financial interests to disclose.
